FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4366771054> ?p ?o ?g. }

• W4366771054 endingPage "7640" @default.
• W4366771054 startingPage "7640" @default.
• W4366771054 abstract "Hepatocellular carcinoma (HCC) has one of the highest mortality rates among solid cancers. Late diagnosis and a lack of efficacious treatment options contribute to the dismal prognosis of HCC. Immune checkpoint inhibitor (ICI)-based immunotherapy has presented a new milestone in the treatment of cancer. Immunotherapy has yielded remarkable treatment responses in a range of cancer types including HCC. Based on the therapeutic effect of ICI alone (programmed cell death (PD)-1/programmed death-ligand1 (PD-L)1 antibody), investigators have developed combined ICI therapies including ICI + ICI, ICI + tyrosine kinase inhibitor (TKI), and ICI + locoregional treatment or novel immunotherapy. Although these regimens have demonstrated increasing treatment efficacy with the addition of novel drugs, the development of biomarkers to predict toxicity and treatment response in patients receiving ICI is in urgent need. PD-L1 expression in tumor cells received the most attention in early studies among various predictive biomarkers. However, PD-L1 expression alone has limited utility as a predictive biomarker in HCC. Accordingly, subsequent studies have evaluated the utility of tumor mutational burden (TMB), gene signatures, and multiplex immunohistochemistry (IHC) as predictive biomarkers. In this review, we aim to discuss the current state of immunotherapy for HCC, the results of the predictive biomarker studies, and future direction." @default.
• W4366771054 created "2023-04-25" @default.
• W4366771054 creator A5024244120 @default.
• W4366771054 creator A5028493964 @default.
• W4366771054 creator A5032561728 @default.
• W4366771054 creator A5033274951 @default.
• W4366771054 creator A5046011924 @default.
• W4366771054 creator A5081273660 @default.
• W4366771054 creator A5091735008 @default.
• W4366771054 date "2023-04-21" @default.
• W4366771054 modified "2023-10-18" @default.
• W4366771054 title "Predictive Biomarkers for Immune-Checkpoint Inhibitor Treatment Response in Patients with Hepatocellular Carcinoma" @default.
• W4366771054 cites W1522156216 @default.
• W4366771054 cites W1538902372 @default.
• W4366771054 cites W1779300534 @default.
• W4366771054 cites W1834481809 @default.
• W4366771054 cites W1916602633 @default.
• W4366771054 cites W1940241680 @default.
• W4366771054 cites W1970902949 @default.
• W4366771054 cites W1974315674 @default.
• W4366771054 cites W1975317266 @default.
• W4366771054 cites W1976385056 @default.
• W4366771054 cites W1976419781 @default.
• W4366771054 cites W1982604280 @default.
• W4366771054 cites W1984484036 @default.
• W4366771054 cites W1986986419 @default.
• W4366771054 cites W1990282402 @default.
• W4366771054 cites W1997983961 @default.
• W4366771054 cites W2004774286 @default.
• W4366771054 cites W2005041705 @default.
• W4366771054 cites W2021582355 @default.
• W4366771054 cites W2028433016 @default.
• W4366771054 cites W2049553585 @default.
• W4366771054 cites W2073511547 @default.
• W4366771054 cites W2073924079 @default.
• W4366771054 cites W2081611490 @default.
• W4366771054 cites W2083672604 @default.
• W4366771054 cites W2093442991 @default.
• W4366771054 cites W2096731080 @default.
• W4366771054 cites W2100519108 @default.
• W4366771054 cites W2100648664 @default.
• W4366771054 cites W2102571808 @default.
• W4366771054 cites W2104885590 @default.
• W4366771054 cites W2107718568 @default.
• W4366771054 cites W2107752337 @default.
• W4366771054 cites W2118471749 @default.
• W4366771054 cites W2119190881 @default.
• W4366771054 cites W2122419529 @default.
• W4366771054 cites W2133775154 @default.
• W4366771054 cites W2136731993 @default.
• W4366771054 cites W2139622109 @default.
• W4366771054 cites W2148207768 @default.
• W4366771054 cites W2149441684 @default.
• W4366771054 cites W2152850571 @default.
• W4366771054 cites W2153936208 @default.
• W4366771054 cites W2158393416 @default.
• W4366771054 cites W2162667703 @default.
• W4366771054 cites W2162889226 @default.
• W4366771054 cites W2164720040 @default.
• W4366771054 cites W2165456770 @default.
• W4366771054 cites W2171154252 @default.
• W4366771054 cites W2171925209 @default.
• W4366771054 cites W2178266085 @default.
• W4366771054 cites W2185075416 @default.
• W4366771054 cites W2217722934 @default.
• W4366771054 cites W2277004004 @default.
• W4366771054 cites W2285065014 @default.
• W4366771054 cites W2293531514 @default.
• W4366771054 cites W2309483848 @default.
• W4366771054 cites W2324094374 @default.
• W4366771054 cites W2343837583 @default.
• W4366771054 cites W2410311439 @default.
• W4366771054 cites W2465860350 @default.
• W4366771054 cites W2467321712 @default.
• W4366771054 cites W2482972152 @default.
• W4366771054 cites W2499029168 @default.
• W4366771054 cites W2511174895 @default.
• W4366771054 cites W2512457722 @default.
• W4366771054 cites W2522220840 @default.
• W4366771054 cites W2522313999 @default.
• W4366771054 cites W2529308344 @default.
• W4366771054 cites W2539128529 @default.
• W4366771054 cites W2539695678 @default.
• W4366771054 cites W2546700240 @default.
• W4366771054 cites W2557336488 @default.
• W4366771054 cites W2559923931 @default.
• W4366771054 cites W2560367415 @default.
• W4366771054 cites W2561459036 @default.
• W4366771054 cites W2562942923 @default.
• W4366771054 cites W2570763587 @default.
• W4366771054 cites W2582671354 @default.
• W4366771054 cites W2591717879 @default.
• W4366771054 cites W2593361213 @default.
• W4366771054 cites W2594274861 @default.
• W4366771054 cites W2601055810 @default.
• W4366771054 cites W2604909450 @default.
• W4366771054 cites W2615907969 @default.
• W4366771054 cites W2617691667 @default.

• next